Biotech Ingredients Market - Global Forecast to 2023

Biotech ingredients are large and complex drugs that are structurally identical to compounds found in natural organisms. These medical drugs are produced using complex biotechnological processes, such as genetic engineering and hybridoma technology as well as biopharmaceutical techniques such as recombinant DNA technology, gene transfer, and antibody production methods. Manufacturing of biotech APIs involves the use of microorganisms or genetically modified organisms, or substances produced by living organisms (like enzymes). Biopharmaceuticals include complex proteins such as antibodies, nucleic acids (like DNA and RNA), or antisense oligonucleotides that are produced by methods which are different from direct extraction from natural, non-engineered organisms.

The growth in this market is mainly driven by the increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in manufacturing, growing importance of generics, rapidly increasing geriatric population, and increasing uptake of biopharmaceuticals.

The report segments the biotech ingredients market based on type, product, and expression system. On the basis of type, the market can be categorized into two segments, namely, innovative biotech APIs and generic biotech APIs (also referred to as biosimilars). On the basis of product, the market is classified into monoclonal antibodies, hormones, vaccines, cytokines, fusion proteins, therapeutic enzymes, and blood factors. On the basis of expression system, biotech ingredients can be categorized into mammalian expression systems, microbial expression systems, yeast expression systems, and other expression systems.

This report is a comprehensive study of current trends in the market, industry growth drivers, and restraints. These markets are given analysis at regional level to provide exhaustive value market analysis for the years 2016, 2017, 2018, and forecast to 2023. Each market is comprehensively analyzed at a granular level by region (North America, Europe, Asia Pacific, and RoW) to provide in-depth information on the global scenario.

Note:The Segmentation Given May Change Depending on Research Findings.The List of Companies May Change as Per Further Research Findings. Top 10 Companies Will Be Profiled in This Section. Details on Overview, Products, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted CompaniesYears Considered for the Study Would Be Historical Year – 2016, Base Year – 2017, Estimated Year – 2018, Forecast Period – 2018 to 2023 The Market Tables Would Include Value Data in USD for the Years 2016, 2017, 2018 and Forecasted Value for 2023 Along With CAGR for the Period 2018-2023

Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).